CD4 and melanoma: They showed that the nanoplatforms were rapidly uptaken by DCs and induced a strong CD4+ (Helper) T-cell and CD8+ (cytotoxic) T cell-mediated immune response, resulting in delayed tumor growth in B16F10 melanoma tumor bearing mice.